DISTRIBUCIONES PHARMA ESTEISY SL
Company details
- Active NIF/CIF: B66180720
-
-
-
-
Address: Carrer de Tavern, 5, 08021 Barcelona, Barcelona, España See in map
-
-
Featured products:
More information on DISTRIBUCIONES PHARMA ESTEISY SL
-
26/03/2014 | BORME act no.: 135185 | Register: BARCELONAOtros conceptos
-
14/03/2014 | BORME act no.: 116197 | Register: BARCELONARevocaciones
-
14/03/2014 | BORME act no.: 116197 | Register: BARCELONANombramientos
-
19/12/2013 | BORME act no.: 542067 | Register: BARCELONAConstitución
-
19/12/2013 | BORME act no.: 542067 | Register: BARCELONANombramientos
Other information
The CIF assigned to DISTRIBUCIONES PHARMA ESTEISY SL is B66180720, while its current business status is active. The company operates in the economic sector identified by the CNAE 412 - Construcción de edificios. In addition, its activity corresponds to the SIC classification 6552 - Urbanizadoras y promotoras.
The template of DISTRIBUCIONES PHARMA ESTEISY SL includes Between 10 and 49 employees, and the company reports an annual turnover of less than 2 million euros. DISTRIBUCIONES PHARMA ESTEISY SL is registered in the Mercantile Registry of Barcelona and accumulates a total of 2 registration charges. The most recent announcement in Borme was published on 26/03/2014, while its last deposit of ordinary annual accounts is related to the - exercise.
If you want to obtain contact information for DISTRIBUCIONES PHARMA ESTEISY SL, such as the telephone number, postal address, or website, you can consult our Company Data module.
To access more details about DISTRIBUCIONES PHARMA ESTEISY SL, consider reviewing one of our available financial reports, the company's Annual Accounts, or verifying its outstanding payments registered in the RAI delinquency file.
The financial, commercial, and legal information provided about DISTRIBUCIONES PHARMA ESTEISY SL comes from official data sources and is automatically updated every day.
Do you want to know more about DISTRIBUCIONES PHARMA ESTEISY SL??
Find out more about this company by consulting these reports: